PEG-GHRF - Serono
Alternative Names: pegylated growth hormone releasing factor; Pegylated growth hormone releasing factor - SeronoLatest Information Update: 26 Jan 2005
At a glance
- Originator Merck Serono
- Class
- Mechanism of Action Growth hormone releasing factor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Growth disorders
Most Recent Events
- 22 Dec 2004 Discontinued - Phase-I for Growth disorders in Switzerland (unspecified route)
- 12 Jun 2003 Phase-I clinical trials in Growth disorders in Switzerland (unspecified route)